Industry News
Nine Cigar Makers Sue FDA for $10 Million in User-Fee Refunds
The premium cigar industry's long fight with the FDA has entered a new phase — this time with cigar makers on offense. According to trade outlets Tobacco Reporter and halfwheel, nine well-known premium cigar manufacturers filed suit on or around July 10, 2026, seeking more than $10 million, plus interest, in refunds of user fees they paid the agency between 2016 and 2023. It is a bid to recover money the companies argue they never should have owed.
What the Lawsuit Claims
The complaint, filed in the U.S. Court of Federal Claims, was brought by a roster of familiar names: Arturo Fuente, Ashton, CLE Cigar, J.C. Newman, Oliva, La Flor Dominicana, My Father Cigars, Padrón, and Rocky Patel.
Their argument builds directly on the industry's earlier courtroom win. After the FDA's 2016 "deeming" rule pulled cigars under its authority, premium cigars were later found by the courts to be improperly regulated — and the agency stopped collecting user fees on them following a key 2023 ruling. The manufacturers now contend that if the FDA lacked the authority to regulate premium cigars, it also lacked the authority to charge them user fees during those years. So they want the money back.
The sums are meaningful. The per-cigar fee was small — roughly 5 to 10 cents depending on the year — but it added up across millions of cigars. Tobacco Reporter notes that court filings in the earlier litigation suggested the federal government could ultimately be on the hook for more than $100 million in total past user-fee refunds if the broader industry pursues similar claims. This legal landscape is a frequent topic in our Tobacco Guide: Pipe Tobacco, Wraps, Cigarillos & Pouches.
The Honest Caveats
A lawsuit is a claim, not a payout. The government has not conceded the refunds, and the Court of Federal Claims process can be slow; the companies must still prove their entitlement to the money, and the outcome is far from guaranteed. It is also worth noting this dispute is about fees and money — not about cigar safety. Nothing here changes the health profile of the product, and Corona Cigars and other premium cigars remain a combustible tobacco product with real risks.
What it Means for Shoppers and Retailers
- No immediate price effect: This case is about refunding fees already paid years ago, not about current pricing. Shoppers won't see cheaper cigars because of the filing itself.
- It reinforces the exemption: The suit is another sign the industry believes its hard-won exemption from FDA cigar regulation is durable — a backdrop that has supported steady premium-cigar availability. This stability is reflected in The Latest Cigar Numbers showing handmade imports holding firm.
- The fight isn't over: Exemptions can be revisited by Congress or the courts, and separate flavor and tax battles continue. Today's news is one thread in a larger, ongoing regulatory story, much like the California’s Flavor Ban impacting various Tobacco Products.
The Bottom Line
Nine of the biggest names in handmade cigars are asking a federal court to return more than $10 million in fees they say they were wrongly charged — a move that could open the door to far larger refunds across the industry.
For cigar buyers, it is less about the shelf price today and more about a signal: the premium cigar business is pressing its regulatory advantage, and the legal wrangling with the FDA is nowhere near finished. This development follows other legislative efforts like The Cigar Jobs Act, which seeks to codify these exemptions into law. While this case focuses on high-end brands, the regulatory environment also affects Filtered Cigars and Black and Mild Flavors which face different tax pressures as seen in recent Pipe Tobacco and Smokeless tax updates.